Your search history is turned on.
Date: July 14, 2011 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
Microsoft Word - 304948_1.DOC 304948-1 NOTICE OF CHANGE IN CORPORATE STRUCTURE Pursuant to Section 4.9 of National Instrument 51-102 Continuous Disclosure Obligations 1. Names of Parties to the Transaction Angiotech Pharmaceuticals, Inc. (the Company), and 0741693 B.C. Ltd., Angiotech International Holdings Corp., Angiotech Pharmaceuticals (US...
Date: June 10, 2011 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
BlueMountain INITIAL ALTERNATIVE MONTHLY REPORT PART 4, NATIONAL INSTRUMENT 62-103 RE: ANGIOTECH PHARMACEUTICALS INC. ("ANGIOTECH") 1. The name and address of the eligible institutional investor: Address: BlueMountain Capital Management, LLC 280 Park Avenue, 5th Fl. E., New York, NY 10017 Name: 2. The net increase or decrease in the numbe...
BeachPointAlternative INITIAL ALTERNATIVE MONTHLY REPORT PART 4, NATIONAL INSTRUMENT 62-103 RE: ANGIOTECH PHARMACEUTICALS INC. ("ANGIOTECH") 1. The name and address of the eligible institutional investor: Address: Beach Point Capital Management LP ("Beach Point") 1620 26th Street, Suite 6000N Santa Monica, California 90404 U.S.A. Name: 2....
CourageAlternative INITIAL ALTERNATIVE MONTHLY REPORT PART 4, NATIONAL INSTRUMENT 62-103 RE: ANGIOTECH PHARMACEUTICALS INC. ("ANGIOTECH") 1. The name and address of the eligible institutional investor: Name: Courage Capital Management, LLC Address: 4400 Harding Rd., Suite 503, Nashville, TN 37205 2. The net increase or decrease in the number or...
Date: May 24, 2011 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
printmgr file Exhibit 10.1 EXECUTION VERSION CREDIT AGREEMENT by and among ANGIOTECH PHARMACEUTICALS, INC. as Parent, THE SUBSIDIARIES OF PARENT LISTED AS BORROWERS ON THE SIGNATURE PAGES HERETO as Borrowers, THE LENDERS THAT ARE SIGNATORIES HERETO as Lenders, and WELLS FARGO CAPITAL FINANCE, LLC as Arranger and...
printmgr file Exhibit 10.2 EXECUTION COPY REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this Agreement) is made as of May 12, 2011, by and among Angiotech Pharmaceuticals, Inc., a corporation organized under the Business Corporations Act of the Province of British Columbia (the Company) and each of the parties listed on the signature pages hereto ...
printmgr file Exhibit 10.3 ANGIOTECH PHARMACEUTICALS, INC. 2011 STOCK INCENTIVE PLAN Angiotech Pharmaceuticals, Inc. (the Company) hereby establishes an equity-based long-term incentive compensation plan for Key Persons (as defined below), to be known as the 2011 Stock Incentive Plan (the Plan). The purpose of the Plan is to promote the long-term success of the...
printmgr file Exhibit 10.7 ANGIOTECH PHARMACEUTICALS, INC. 2011 STOCK INCENTIVE PLAN STOCK OPTION/SAR AWARD AGREEMENT (for U.S. Participants) Angiotech Pharmaceuticals, Inc. (the Company) hereby grants the following Award to the Participant named below (the Participant), in accordance with and subject to the terms, conditions and restrictions of this Award Agr...
printmgr file Exhibit 10.5 ANGIOTECH PHARMACEUTICALS, INC. 2011 STOCK INCENTIVE PLAN RETRICTED STOCK AWARD AGREEMENT (for U.S. Participants) Angiotech Pharmaceuticals, Inc. (the Company) hereby grants the following Award to the Participant named below (the Participant), in accordance with and subject to the terms, conditions and restrictions of this Award Agreeme...
printmgr file Exhibit 10.6 ANGIOTECH PHARMACEUTICALS, INC. 2011 STOCK INCENTIVE PLAN STOCK OPTION/SAR AWARD AGREEMENT (for Canadian Participants) Angiotech Pharmaceuticals, Inc. (the Company) hereby grants the following Award to the Participant named below (the Participant), in accordance with and subject to the terms, conditions and restrictions of this Award...